NCT04343287 - Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

June 23, 2020

Study Completion Date

June 23, 2020

Conditions

Dry Eye Syndrome

Interventions

DRUG

BRM421

The active control with BRM421 solution

DRUG

Placebo

The vehicle solution

Trial Locations (4)

Total Eye Care, Memphis

Midwest Cornea Associates, LLC, Indianapolis

Eye Research Foundation, Newport Beach

Andover Eye Associates, Andover